News

April 4, 2017

Lars Rebien Sørensen elected to the Board of Directors of Novo A/S

For 16 years, Lars Rebien Sørensen was President and CEO of Novo Nordisk A/S, a leading global pharmaceutical company with a focus on diabetes care. With Lars Rebien Sørensen at the helm, the company’s annual results increased markedly, and in 2016 the company produced its best results ever. Harvard Business Review ranked Lars Rebien Sørensen as the world’s top-performing CEO in 2015 and 2016.